Arnies your above post states the 'extension' trial, but the quotes in your follow up post seem to indicate the Phase 3 trial (the first one specifically).
For the P3 nobody would know whether they were on the drug or placebo - therefore one or both could be causing the reaction (long bow I know)
Also if the reaction was widespread in the P3 trial it could be a possible indicator of who was on the drug and who wasn't.
If the reactions are in the extension trial, it would mean that the participant was most likely on the placebo in the P3.
If reactions were too widespread the trial would be pulled.
Very confusing situation.
Perhaps your post has caused today's sudden drop. (That is in no way a criticism of you making the info available.)
Getting sick of this stock and due to the SP situation have always had a nagging worry that the reason could be that there are stories floating around about problems - i.e. SP woes not due to manipulation at all.
Seriously considering getting out. Too many other good opportunities about. But that would be a pity after all this time with such high hopes.
What a dog stock it has turned out to be.
I know all the above is a bit rambling, but ....
NEU Price at posting:
$1.28 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)